Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0271276 (
Hudson
)
1,066
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The primary region of
factor IX
that mediates binding to bovine aortic endothelial cells resides in residues 3-11 of the N-terminal region known as the Gla domain. Recently, it was proposed that the observed binding to endothelial cells is actually a measure of the interaction between
factor IX
and collagen IV (Cheung, W. F., van den Born, J., Kuhn, K., Kjellen, L.,
Hudson
, B. G., and Stafford, D. W. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 11068-11073). To confirm that
factor IX
binds to collagen IV and to examine the specificity of this interaction, we used scanning force microscopy to examine
factor IX
binding to collagen IV. We imaged collagen IV in the presence and the absence of
factor IX
and observed specific interactions between
factor IX
and collagen IV. Our results demonstrate that
factor IX
binds to collagen IV at specific sites in the collagenous domain approximately 98 and approximately 50 nm from the C-terminal pepsin-cleaved end.
...
PMID:Human factor IX binds to specific sites on the collagenous domain of collagen IV. 920 71